Introduction to the third international symposium on Charcot-Marie-Tooth disorders

Annals of the New York Academy of Sciences

Volumn 883, Issue , 1999, Pages

  Shy, Michael E ^a   Kamholz, John ^a   Lovelace, Robert E ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; PMP22 PROTEIN, HUMAN;

ANIMAL; CHROMOSOME 17; GENE DUPLICATION; GENE THERAPY; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; REVIEW;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; CHROMOSOMES, HUMAN, PAIR 17; GENE DUPLICATION; GENE THERAPY; HUMANS; MYELIN PROTEINS;

EID: 0033554312     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08559.x     Document Type: Conference Paper

References (52)

1. SKRE, H. 1974. Genetic and clinical aspects of Charcot Marie Tooth's disease. Proceedings of the Third International Congress on Clinical Genetics Muscle Diseases 6: 98-118.
2. DYCK, P.J., P. CHANCE R. LEBO & J.A. CARNEY. 1993. Heriditary and sensory neuropathies. In Peripheral Neuropathy. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low & J.F. Poduslo, Eds.: 1094-1127. WB Saunders. Philadelphia/London/Toronto/Montreal.
3. CHARCOT, J.M. & P. MARIE. 1886. Sur une forme particulaire d'atrophie musculaire progressive souvent familial debutant par les pieds et les jambes et atteingnant plus tard les mains. Rev. Med. 6: 97-138.
4. AGUAYO, A.J., S. PERKINS, G. BRAY & I. DUNCAN. 1978. Transplantation of nerve from patients with Charcot-Marie-Tooth (CMT) disease into immune-suppressed mice. J. Neuropathol. Exp. Neurol. 37: 582.
5. LUPSKI, J.R., R. MONTES DE OCA-LUNA, S. SLAUGENHAUPT, L. PENTAO, V. GUZZETTA, B.J. TRASK, O. SAUCEDO-CARDENAS, D.F. BARKER, J.M. KILLIAN, C.A. GARCIA, A. CHAKRAVARTI, & P.I. PATEL. 1991. DNA duplication associated with Charcot-Marie-Tooth Disease Type 1A. Cell 66: 219-232.
6. HOOGENDIJK, J.E., G.W. HENSELS, I. ZORN, L. VALENTIJN, et al. 1991. The duplication in Charcot-Marie-Tooth disease type 1A spans at least 1100 kb on chromosome 17p11.2. Hum. Genet. 88: 215-218.
7. RAEYMAEKERS, P., V. TIMMERMAN, E. NELIS, J.P. DE, et al. 1991. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromusc. Disord. 1: 93-97.
8. PATEL, P.I., B.B. ROA, A.A. WELCHER, S.R. SCHOENER, et al. 1992. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 159-165.
9. MATSUNAMI, N., B. SMITH, L. BALLARD, M.W. LENSCH, et al. 1992. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat. Genet. 1: 176-179.
10. TIMMERMAN, V., E. NELIS, H.W. VAN, B.W. NIEUWENHUIJSEN, et al. 1992. The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication [published erratum appears in Nat. Genet. 1992 Sept. 2(1): 84]. Nat. Genet. 1: 171-175.
11. VALENTIJN, L.J., P.A. BOLHUIS, I. ZORN, J.E. HOOGENDIJK, et al. 1992. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 166-170.
12. SUTER, U., A.A. WELCHER, T. OZCELIK, G.J. SNIPES, et al. 1992. Trembler mouse carries a point mutation in a myelin gene. Nature 356: 241-244.
13. SUTER, U., J.J. MOSKOW, A.A. WELCHER, G.J. SNIPES, et al. 1992. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA 89: 4382-4386.
14. VALENTIJN, L.J., F. BAAS, R.A. WOLTERMAN, J.E. HOOGENDIJK, et al. 1992. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2: 288-291.
15. CHANCE, P.F., M.K. ALDERSON, K.A. LEPPIG, M.W. LENSCH, et al. 1993. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151.
16. HAYASAKA, K., A. OHNISHI, G. TAKADA, Y. FUKUSHIMA, et al. 1993. Mutation of the myelin po gene in Charcot-Marie-Tooth neuropathy type-1. Biochem. Biophys. Res. Commun. 194: 1317-1322.
17. WARNER, L.E., P. MANCIAS, I.J. BUTLER, C.M. MCDONALD, et al. 1998. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathics. Nat. Genet. 18: 382-384.
18. BERGOFFEN, J., S.S. SCHERER, S. WANG, M. ORONZI-SCOTT, et al. 1993. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 3039-2042.
19. TIMMERMAN, V., P. DEJONGHE, P. SPOELDERS, S. SIMOKOVIC, et al. 1996. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and xq13. Neurology 46: 1311-1318.
20. LEMKE, G. & M. CHAO. 1988, Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development 102: 499-504.
21. YOSHIKAWA, H., T. NISHIMURA, Y. NAKATSUJI, H. FUJIMURA, et al. 1994. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann. Neurol. 35: 445-450.
22. HANEMANN, C.O., G. STOLL, D. DURSO, W. FRICKE, et al. 1994. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1A sural nerve biopsies. J. Neurosci. Res. 37: 654-659.
23. VALLAT, J.M., P. SINDOU, P.M. PREUX, F. TABARAUD, et al. 1996. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann. Neurol. 39; 813-817.
24. READHEAD, C., A. SCHNEIDER, I. GRIFFITHS & K. A. NAVE. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12: 583-595.
25. KAGAWA, T., K. IKENAKA, Y. INOUE, S. KURIYAMA, et al. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427-442.
26. SEREDA, M., I. GRIFFITHS, A. PUHLHOFER, et al. 1996. A transgeneic rat model of Charcot-Marie-Tooth disease. Neuron 16: 1049-1060.
27. HUXLEY, C., E. PASSAGE, A. MANSON, G. PUTZU, et al. 1996. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5: 563-569.
28. WARNER, L.E., M.J. HILZ, S.H. APPEL, J.M. KILLIAN, et al. 1996. Clinical phenotypes of different MPZ (P-0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 17: 451-460.
29. 0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem. Biophys. Res. Commun. 222: 107-110.
30. SUTER, U. & J. SNIPES. 1995. Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18: 45-75.
31. SHAPIRO, L., J.P. DOYLE, P. HENSLEY, D.R. COLMAN, et al. 1996. Crystal structure of the extracellular domain from P-0, the major structural protein of peripheral nerve myelin. Neuron 17: 435-449.
32. 0 knockout mice develop a peripheral neruopathy that resembles chronic inflammatory demyelinating polyneuropthy (CIDP). J. Neuropathol. Exp. Neurol. 56(7): 811-821.
33. 0 gene mutations. Muscle Nerve 19: 946-952.
34. 0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited hyman neuropathies. Nat. Genet. 11: 281-285.
35. SCHERER, S.S. 1996. Molecular specializations at nodes and paranodes in peripheral nerve. Microsc. Res. Tech. 34: 452-461.
36. BERCIANO, J., O. COMBARROS, J. CALLEJA, J.M. POLO, et al. 1989. The application of nerve conduction and clinical studies to genetic counseliling in hereditary and sensory neuropathy type I. Muscle Nerve 12: 302-306.
37. BOUCHE, P., R. GHERARDI, H.P. CATHALA, J. LHERMITE, et al. 1983. Peroneal muscular atrophy. Part 1, Clinical and electrophysiological study. J. Neurol. Sci. 61: 389-399.
38. COMBARROS, O., J. CALLEJA & J.M. POLO. 1989. Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol. Scand. 75: 9-12.
39. DAVIS, C.J.F., W.G. BRADLEY & R. MADRID. 1978. The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies I. Clinical, genetic and electrophysiological findings and classification. J. Genet, Hum. 26: 311-349.
40. DYCK, P.J. & E.H. LAMBERT. 1968. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch. Neurol. 18: 603-618.
41. DYCK, P.J. 1984. Inherited neuronal degeneration and atrophy affecting peripheral motor, sensory, and autonomic neurons. In Peripheral Neuropathy. P.J. Dyck, P.K. Thomas, E.H. Lambert & R.E. Bunge, Eds.: 1600-1642. W.B. Saunders. Philadelphia.
42. HARDING, A.E. & P.K. THOMAS. 1980. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103: 259-280.
43. LEWIS, R.A. & A.J. SUMNER. 1982. The electrodiagnostic distinctions between chronic familial and acquired demyelinating neuropathies. Neurology 32: 592-596.
44. KAKU, D.A., G.J. PARRY, R. MALAMUT, J.R. LUPSKI, et al. 1993. Uniform slowing of conduction velocities in Charcot-Marie-Tooth disease polyneuropathy type 1. Neurology 434: 2664-2667.
45. BIROUK, M., E. LEGUERN, T. MAISONOBE, H. ROUGER, et al. 1998. Neurologie 50: 1074-1082.
46. SHY, M.E., M. TANI, Y.J. SHI, S.A. WHYATT, et al. 1995. An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve. Ann. Neurol. 38: 429-436.
47. LOCHMULLER, H., B.J. PETROF, G. PARI, N. LAROCHELLE, et al. 1996. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene. Ther. 3: 706-716.
48. ACSADI, G., B. MASSIE & A. JANI. 1995. Adenovirus-mediated gene transfer into striated muscles. J. Mol. Med. 73: 165-180.
49. GIMENEZ Y RIBOITA, M., F. REVAH, L. PRADIER, I. LOQUET, et al. 1997, Prevention of motoneuron death by adenovirus-mediated neurotiophic factors. J. Neurosci. Res. 48: 281-285.
50. HAASE, G., P. KENNEL, B. PETTMAN, E. VIGNE, et al. 1997. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat. Med. 3: 429-436.
51. KRAMER, R., Y. ZHANG, J. GEHRMANN, R. GOLD, et al. 1995. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis, Nat. Med. 11: 1162-1166.
52. ACSADI, G., B. MASSIE & A. JANI. 1995. Adenovirus-mediated gene transfer into striated muscles. J. Mol. Med. 73: 165-180.